Skip to main content
AAO-HNSF 2025 Annual Meeting & OTO EXPO Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

On behalf of the AK-OTOF trial sponsored by Akouos and Lilly

Sponsor
Eli Lilly and Company
Boston, MA, United States

Eli Lilly and Company is the sponsor of ClinicalTrials.gov ID NCT05821959 (Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss). They are developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for individuals living with hearing loss. AK-OTOF and the Akouos Delivery Device are investigational and not approved by FDA or any other regulatory authority.


Disclosure information not submitted.

Presentation(s):